AstraZeneca’s New Study on Durvalumab for Lung Cancer: Market Implications

1 month ago 25

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has announced a new clinical study titled ‘Durvalumab Consolidation After Chem...

1. Homepage
2. Lung Cancer
3. AstraZeneca’s New Study on Durvalumab for Lung Cancer: Market Implications